Neither verdict could be appealed to a court. Trump doesn't have to worry about being removed from office, but if he's convicted, the Senate could then hold a second vote to disqualify him from ever holding national office again. That penalty would need a simple majority of 51 votes to pass. The entire Senate hears the case, but has more power than a typical civil or criminal jury. In addition to being able to vote on procedures and evidence, senators can submit questions and objections to the presiding officer.
And while judges strive to pick unbiased civil and criminal juries, that's not the case here. The Senate is currently evenly divided between Democrats and Republicans. If there's a split on a trial issue, Vice President Kamala Harris could act as a tie-breaking vote. While a vice president is typically excluded from involvement in a presidential impeachment trial because of conflict of interest issues, Trump's status as a former president renders that issue moot.
There are nine impeachment managers , who essentially act as the prosecutors in the case. The roster is entirely different from the first impeachment trial. Jamie Raskin, D-Md. He's joined by Reps. Diana DeGette, D-Colo. Virgin Islands. The former president will also have a different roster of lawyers than he had in his previous trial, and different lawyers than he had originally lined up. It may lead to therapies getting approval even with insufficient effectiveness, exposing patients to greater risks.
False-positive Phase III trials could create a major financial burden on patients and therapy producers. The Phase III trials evaluated for this study were mostly two-arm studies of an interventional candidate versus a control.
Serum total T4 T4 concentrations [ Time Frame: 24 months ] Evaluate the effect of tiratricol on T4 concentrations to ensure patient safety.
Serum tiratricol concentrations [ Time Frame: 24 months ] Evaluate tiratricol concentrations in serum, as estimated based on measured T3 concentrations in serum. Serum reverse T3 rT3 concentrations [ Time Frame: 24 months ] Evaluate the effect of tiratricol on rT3 concentrations to ensure patient safety.
Serum alkaline phosphatase concentrations [ Time Frame: 24 months ] Evaluate the effect of tiratricol on alkaline phosphatase concentrations to ensure patient safety. Serum albumin concentrations [ Time Frame: 24 months ] Evaluate the effect of tiratricol on albumin concentrations to ensure patient safety. Serum urea concentrations [ Time Frame: 24 months ] Evaluate the effect of tiratricol on urea concentrations to ensure patient safety. Serum sodium concentrations [ Time Frame: 24 months ] Evaluate the effect of tiratricol on sodium concentrations to ensure patient safety.
Serum potassium concentrations [ Time Frame: 24 months ] Evaluate the effect of tiratricol on potassium concentrations to ensure patient safety.
White blood cell total and differential count [ Time Frame: 24 months ] Evaluate the effect of tiratricol on white blood cell total and differential count to ensure patient safety. Red blood cell count [ Time Frame: 24 months ] Evaluate the effect of tiratricol on red blood cell count to ensure patient safety.
Platelet count [ Time Frame: 24 months ] Evaluate the effect of tiratricol on platelet cell count to ensure patient safety. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below.
For general information, Learn About Clinical Studies. Try the modernized ClinicalTrials. Learn more about the modernization effort. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Search for terms. Save this study. Warning You have reached the maximum number of saved studies Listing a study does not mean it has been evaluated by the U.
Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Last Update Posted : June 25, See Contacts and Locations. Study Description. Patients will be treated for 24 months with tiratricol, treatment effect on neurodevelopment impairment caused by hypothyroidism and the thyrotoxicosis will be evaluated at an interim analysis after 12 months treatment and after 24 months treatment.
Detailed Description:. Drug Information available for: Guaifenesin Phenylpropanolamine hydrochloride Triaminic Phenylpropanolamine. FDA Resources. Arms and Interventions. Keywords: Chemoradiotherapy; S-1; cisplatin; head and neck cancer; unresectable. Abstract We conducted a phase II study to evaluate the efficacy and safety of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
0コメント